• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

News of the day

PR Newswire search

Most viewed

Cervical Cancer Charity Welcomes Department of Health's Announcement About HPV Vaccine

Teva Welcomes Pharmacy White Paper

Moleac Announces Series A Investment

Dr. Ari Kiev to Address Biotechnology Conference, Wall Street Unplugged: The Trout Group Investor Seminar, in Munich April 7

U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform

Browse by category

• Acquisitions, Mergers and Takeovers
• Animals/Pets
• Asian Related News
• Awards
• Broadcast Feed Announcement
• Children Related News
• Clinical Trials/Medical Discoveries
• Conference Call Announcements
• Contracts
• Corporate Social Responsibility
• Dividends
• Domestic Policy
• Earnings
• Earnings Projections or Forecasts
• European Government
• FDA Approval
• Financial Agreements
• Foreign Policy
• Handicapped/Disabled
• Hispanic Oriented News
• Joint Ventures
• Labor News
• Legal Issues
• Lesbian/Gay/Bisexual
• Licensing/Marketing Agreements
• Media Advisory/Invitation
• New Products/Services
• Not for profit
• Offerings
• OTC/Small Cap IRW
• Patent Law
• Personnel Announcements
• Political Campaigns
• Public Safety
• Real Estate Transactions
• Religion
• Sales Reports
• Senior Citizens
• Surveys, Polls and Research
• Trade Shows
• Venture Capital
• Veterans
• Women Related News

More recent news

Organizational Changes at Silence Therapeutics
17th July 2008 LONDON, July 17 /PRNewswire/ -- Silence Therapeutics plc (London AIM: SLN), a leading European RNAi focused biotechnology company, announces that for personal reasons, Jeffery Vick has resigned as...

Tickets for Brand New Exhibition 'Body Worlds & The Mirror of Time' on Sale 18 July
17th July 2008 LONDON, July 18 /PRNewswire/ -- Tickets to the next blockbuster exhibition to premiere at The O2, Body Worlds & The Mirror of Time from physician, scientist and anatomist Dr. Gunther von Hagens, go...

Unite NHS Members Say 'Cut My Pay - No Way!'
17th July 2008 LONDON, July 18 /PRNewswire/ -- Unite members across the NHS will today (Friday 18th July) send a strong message to government to say: "Cut my pay - No Way!" In a national day of protest NHS staff...

Seal Shield to Launch World's First Dishwasher Safe, Antimicrobial Keyboard with Multi-Language Support for International Markets
17th July 2008 JACKSONVILLE, Florida, July 17 /PRNewswire/ -- Seal Shield LLC has begun shipping a new family of fully submersible, 108 key, International keyboards with SILVER SEAL Antimicrobial protection to help...

New, Informative EAU Website Launched: http://www.urologyweek.org
17th July 2008 ARNHEM, The Netherlands, July 17 /PRNewswire/ -- The European Association of Urology (EAU) launched a new website recently as platform for the promotional activities for the first European Urology...

UK Businesses Urged to Help Employees Deal With Stress More Positively
17th July 2008 FRIMLEY, England, July 17 /PRNewswire/ -- UK workers are most likely to turn to alcohol, smoking and comfort eating to help them deal with the stress of their occupations, according to a new 'Stroke...

Essilor - First-Half 2008 Revenue
17th July 2008 CHARENTON-LE-PONT, France, July 17 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR1,520.3 million for the six months...

AMT Appoints Director Global Marketing and Sales
17th July 2008 AMSTERDAM, The Netherlands, July 17 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today the appointment of Mrs. Janneke de...

The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
17th July 2008 PHILADELPHIA and LONDON, July 17 /PRNewswire/ -- The Scientific business of Thomson Reuters today announced the early findings of its 2008 Liquent Regulatory Affairs Trends Survey. The...

Galderma Announces Approval for Differin(R) Gel 0.1% in Japan
17th July 2008 LAUSANNE, Switzerland, July 17 /PRNewswire/ -- Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, announced today that Japan's Ministry of Health, Labor...

South America - Pharma Events Confirmed for This Year and 2009
16th July 2008 LONDON, July 16 /PRNewswire/ -- CMPi events for the fast-developing pharma markets of South and Latin America debut next month. Rio de Janeiro will host the twin launch of the CPhI South America...

London Restaurant Launches UK's First "Pregnancy Pizza"
16th July 2008 LONDON, July 16 /PRNewswire/ -- A London pizza restaurant has launched the UK's first range of pizzas designed specifically for pregnant women. The Pregnancy Pizzas were devised by owner...

Max Planck Society Awards Exclusive License to Dafra Pharma R&D to Develop a Drug Against Leishmaniasis
16th July 2008 TURNHOUT, Belgium, July 16 /PRNewswire/ -- Max Planck Innovation, the technology transfer agency of the Max Planck Society based in Munich, Germany and Dafra Pharma R&D, a Belgian research company...

Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
16th July 2008 NOVATO, California, July 16 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced the execution of a collaboration agreement...

BioWa and Medarex Announce License of BioWa's COMPLEGENT(TM) Technology
16th July 2008 PRINCETON, New Jersey, July 16 /PRNewswire/ -- BioWa, Inc. and Medarex, Inc. (Nasdaq: MEDX) announced today that they have entered into a license agreement which provides Medarex with the first ever...

Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
16th July 2008 FREISING-WEIHENSTEPHAN and JENA, Germany, July 16 /PRNewswire/ -- Pieris AG, a bio-pharmaceutical company developing Anticalins(R), a novel class of targeted human protein therapeutics, and Wacker...

Physicians Practice and Nevada Cancer Institute Partner to Improve Patient Care
15th July 2008 BALTIMORE, July 15 /PRNewswire/ -- Physicians and patients of community-based medical practices in Nevada and SW Utah will benefit from a new partnership between Physicians Practice(R), America's...

Jerini Receives European Commission Approval for FIRAZYR(R) (Icatibant) in the Treatment of HAE
15th July 2008 BASINGSTOKE, England and CAMBRIDGE, Massachusetts, July 15 /PRNewswire/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, notes that Jerini AG (FSE:JI4) has...

EyeGate Pharma Initiates Landmark Clinical Study Employing the EyeGate(R) II Non-Invasive Ocular Delivery System in Acute Anterior Uveitis
15th July 2008 WALTHAM, Massachusetts, July 15 /PRNewswire/ -- EyeGate Pharma, a privately held specialty pharmaceutical company using iontophoresis technology to safely and non-invasively deliver therapeutics into...

Ingenuity Systems and CHDI Announce Multi-Year Deal for Disease-Specific Knowledge Platform
15th July 2008 REDWOOD CITY, California, July 15 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, and CHDI Foundation, Inc., a non-profit...

Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets
15th July 2008 AMSTERDAM, Netherlands and BARCELONA, Spain, July 15 /PRNewswire/ -- Agendia BV and Ferrer inCode today announced an agreement that will give Ferrer exclusive rights to sell two of Agendia's...

Gerresheimer Further Increases its Sales and Earnings Power
15th July 2008 DÜSSELDORF, Germany, July 15 /PRNewswire/ --

First International Cancer Film Festival Announces Finalists
15th July 2008 GENEVA, Switzerland, July 15 /PRNewswire/ -- The finalists for Reel Lives: The Cancer Chronicles, the first ever international documentary film competition on cancer, are announced today in a line-up...

AMT Starts Collaboration With St. Jude Children's Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
15th July 2008 AMSTERDAM, The Netherlands, July 15 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced the start of a collaboration with...

Informex365.com is Launched for Manufacturers in Search of Chemical Reactions Expertise
14th July 2008 PRINCETON, New Jersey, July 14 /PRNewswire/ -- Informex has launched Informex365.com, a new web portal for manufacturers that require service and support in chemical reactions commonly used in...

Study: Global Business Performance Significantly Improved Through Project Management
14th July 2008 WARSAW, Poland, July 14 /PRNewswire/ -- Preliminary findings from a landmark independent, academic study on the value of project management, released today at the Project Management Institute's...

Diabetes Online Health Guide Released on NHS Choices
14th July 2008 LONDON, July 14 /PRNewswire/ -- An online NHS Health Guide for people with diabetes has been launched on the national NHS website, NHS Choices http://www.nhs.uk The guide,...

Elsevier's "ScienceDirect" Articles Surpass Nine-Million Mark
14th July 2008 AMSTERDAM, The Netherlands, July 14 /PRNewswire/ -- Elsevier, a leading publisher of scientific, technical and medical (STM) information, today announced that its online scientific research...

Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board
14th July 2008 NOVATO, California, July 14 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today announced the appointments of Richard L. Franklin, M.D., Ph.D. to the Company's board of...

Goldshield Wins SFO Case - Interview With Chairman and CEO
11th July 2008 LONDON, July 11 /PRNewswire/ -- Goldshield Group UK, the pharmaceutical and healthcare company, said today a judge had refused the application of the Serious Fraud Office (SFO) to amend its...

Silence Therapeutics Announces Successful Opposition of Glover Patent
11th July 2008 LONDON, July 11 /PRNewswire/ -- Silence Therapeutics plc (London AIM: SLN), a leading European RNA interference (RNAi) focused biotechnology company, announced today the successful opposition of a...

Online NHS Health Guides for Long-Term Conditions Released on NHS Choices
11th July 2008 LONDON, July 11 /PRNewswire/ -- A series of online NHS Health Guides for people with long-term conditions have been launched today on the national NHS website, NHS Choices http://www.nhs.uk ...

Advance Notice - Unite NHS Day of Protest Friday 18th July
11th July 2008 LONDON, July 11 /PRNewswire/ -- Next Friday (18th July 2008) Unite members will stage a series of national protests against the imposition of a three year pay deal. The Unite Day of Protest is...

ESTRO Announces Press Programme for 2008 Annual Congress
11th July 2008 BRUSSELS, Belgium, July 11 /PRNewswire/ -- More than 4,500 cancer and radiotherapy specialists will gather in Göteborg this September for the 27th annual congress of ESTRO. ESTRO 27 is to be held...

RiderSaver(TM) EMF Seat Shield Reduces Motorcycle Cancer Concern
11th July 2008 MISSISSAUGA, Ontario, July 11 /PRNewswire/ -- A new motorcycle seat accessory provides peace of mind for riders concerned about cancer risk. "It's not just about cancer," says Canadian author and...

Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
11th July 2008 SUNRISE, Florida, July 11 /PRNewswire/ -- Bioheart, Inc. (Nasdaq: BHRT), a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and...

Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
10th July 2008 ANTONY, France, July 10 /PRNewswire/ --

CMP is Back This Year with Loads of Innovative Ideas and Varieties of Food Ingredients
10th July 2008 MUMBAI, India, July 10 /PRNewswire/ -- CMP India and CMP Information, The Netherlands, is once again organizing Fi India 2008, a two-day International Exhibition and Conference on Food Ingredients in...

DNA Labelling Increases Protection From Counterfeiting
10th July 2008 STUTTGART, Germany, July 10 /PRNewswire/ -- The proportion of counterfeit products is reported recently from the European commission to be rapidly increasing. There are figures to back this up,...

Pinnacle Biologics Announces Agreement With pharmexx to Expand Sales Support Activities in Key European Markets
10th July 2008 BANNOCKBURN, Illinois, July 10 /PRNewswire/ -- Pinnacle Biologics, a private, full-service pharmaceutical and biotech solutions company today announced it has entered into an agreement with pharmexx...

SmoothToe Diabetic Socks Acquired by Lifestyle Medical Group
9th July 2008 SAINT CHARLES, Minnesota, July 9 /PRNewswire/ -- SmoothToe, the only brand of diabetic socks available anywhere in the world with a Lifetime Blister Free Guarantee as well as a Five Year...

Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study
9th July 2008 COPENHAGEN, Denmark, July 9 /PRNewswire/ -- Summary: Genmab has completed recruitment of patients in the Phase II study of ofatumumab in combination with fludarabine and cyclophosphamide to treat...

Industry Leaders Select Resverlogix's RVX-208 Among Top 10 Most Promising Drugs
9th July 2008 CALGARY, Canada, July 9 /PRNewswire/ -- Resverlogix Corp's ("Resverlogix" or the "Company") (TSX:RVX) novel lead ApoA-I drug candidate, RVX-208 has been selected as one of the top 10 most promising...